Advanced search
1 file | 706.34 KB

Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase ha, open-label study

(2012) JOURNAL OF HEPATOLOGY. 56(6). p.1247-1253
Author
Organization
Keywords
Antiviral, Genotype, Monotherapy, HEPATITIS-C VIRUS, PEGINTERFERON PLUS RIBAVIRIN, RANDOMIZED-TRIAL, INITIAL TREATMENT, DRUG-USERS, EAST, COMBINATION, PREVALENCE, MANAGEMENT, ALPHA-2A, TMC435, HCV

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 706.34 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Moreno, Christophe, Thomas Berg, Tawesak Tanwandee, Satawat Thongsawat, Hans Van Vlierberghe, Stefan Zeuzem, Oliver Lenz, Monika Peeters, Vanitha Sekar, and Goedele De Smedt. 2012. “Antiviral Activity of TMC435 Monotherapy in Patients Infected with HCV Genotypes 2-6: TMC435-C202, a Phase Ha, Open-label Study.” Journal of Hepatology 56 (6): 1247–1253.
APA
Moreno, C., Berg, T., Tanwandee, T., Thongsawat, S., Van Vlierberghe, H., Zeuzem, S., Lenz, O., et al. (2012). Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase ha, open-label study. JOURNAL OF HEPATOLOGY, 56(6), 1247–1253.
Vancouver
1.
Moreno C, Berg T, Tanwandee T, Thongsawat S, Van Vlierberghe H, Zeuzem S, et al. Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase ha, open-label study. JOURNAL OF HEPATOLOGY. 2012;56(6):1247–53.
MLA
Moreno, Christophe, Thomas Berg, Tawesak Tanwandee, et al. “Antiviral Activity of TMC435 Monotherapy in Patients Infected with HCV Genotypes 2-6: TMC435-C202, a Phase Ha, Open-label Study.” JOURNAL OF HEPATOLOGY 56.6 (2012): 1247–1253. Print.
@article{2915697,
  author       = {Moreno, Christophe and Berg, Thomas and Tanwandee, Tawesak and Thongsawat, Satawat and Van Vlierberghe, Hans and Zeuzem, Stefan and Lenz, Oliver and Peeters, Monika and Sekar, Vanitha and De Smedt, Goedele},
  issn         = {0168-8278},
  journal      = {JOURNAL OF HEPATOLOGY},
  keyword      = {Antiviral,Genotype,Monotherapy,HEPATITIS-C VIRUS,PEGINTERFERON PLUS RIBAVIRIN,RANDOMIZED-TRIAL,INITIAL TREATMENT,DRUG-USERS,EAST,COMBINATION,PREVALENCE,MANAGEMENT,ALPHA-2A,TMC435,HCV},
  language     = {eng},
  number       = {6},
  pages        = {1247--1253},
  title        = {Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase ha, open-label study},
  url          = {http://dx.doi.org/10.1016/j.jhep.2011.12.033},
  volume       = {56},
  year         = {2012},
}

Altmetric
View in Altmetric
Web of Science
Times cited: